Pharmafile Logo

Aqurance

Aqurance consults Life Sciences industry to empower with digital solutions their salesforce, implementing top quality technology platforms, through its strategic partnerships. Founded in September 2011, with offices in Athens and Istanbul, is the fastest growing service provider for Life Sciences in South East Europe.
We believe that the future of Pharma is evidence-based. Our mission is to provide and implement effective tools that will help industry professionals make better and more effective decisions. We aim to facilitate Pharma managers in successfully overcoming budgetary and organizational challenges by using technology and data combined.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Egiou 1 & Figaleias Athens, Bilim Sokak Sun Plaza Kat: 13 Istanbul, Greece - Turkey, 14564 - 34398
+30 210 6200 206 - +90 212 366 02 40

 Latest Content from PMHub 

You know more about your audience than you think

Our Digital Lead, Richard Springham, discusses the untapped resources of your digital tools and how they hold the key to targeting your audiences.

How will the NHS’s new medicines savings drive affect pharma?

Steve How and Sue Thomas, of Wilmington Healthcare, explore how pharma should engage with CCGs on prescribing saving targets

Pharma need to keep their ‘pull & push’ separate from their ‘inbound & outbound’

Is your pharma brand using the marketing terms ‘pull & push’ correctly?

A man walks into a surgery: The role of storytelling in pharma marketing

Communicating through stories can make your brand messages more meaningful, memorable and persuasive

Embracing the demands of the empowered ‘consumer-savvy’ patient by Ann Generlich

Our access to information, which is now constantly at our fingertips and the explosion of new technologies has shifted the buying power to increasingly ‘consumer-savvy’ patients. These are patients who choose...

The Art of Agile Marketing

The industry knows that it needs become more responsive to its stakeholders. An agile approach – which quickly improves results through a process of rapid market feedback and response –...

Could ketamine be the next big thing in depression?

Account Executive Will Frostick discusses the established treatment model for depression and its limitations, as well as a new entrant poised to revolutionise the field – ketamine.

Attracting doctors to low-demand specialties: A role for industry?

 One of the major problems that healthcare systems around the world face is a paucity of medically qualified staff entering particular specialties and subspecialties. This can be due to a...

Men vs Women in emerging markets

Our latest interactive infographic compares male vs female health characteristics in the BRIC emerging marketS

South Korea: The next global player?

In this paper, we will explore some of the key trends and outlooks for South Korea in more detail, including what lies behind its presence at the extremes of two...